Sandhoff disease is a recessively inherited lysosomal storage disease resulting from a deficiency of 1-hexosaminidase activity. The enzyme occurs in two major forms, fl-hexosaminidase A, composed of an a-and j-subunit and ft-hexosaminidase B, composed of two 13-subunits. Both isozyme activities are deficient in Sandhoff disease, owing to mutations of the HEXB gene encoding the common ,8-subunit. We have cloned and fully characterized a deletion at the HEXB gene from fibroblasts of a patient with the infantile form of Sandhoff disease. The deletion removes -16 kb of DNA including the HEXB promoter, exons 1-5 and part of intron 5. It most likely arose from recombination between two Alu sequences, with the breakpoints occurring at the midpoint between the left and right arms in each case and regenerating an intact Alu element in the deletion sequence. The deletion allele accounts for 27% of the Sandhoff mutant alleles we analyzed. Two cell lines were shown to be homozygous for the deletion and both had the infantile form of the disease. Four additional patients were compound heterozygotes with other mutations, all of whom displayed a different clinical phenotype. Finally, the mutant allele was present in different ethnic backgrounds, suggesting that it may have been subject to genetic drift. (J. Clin. Invest.
Introduction
The GM2 gangliosidoses are a group of inherited disorders resulting from excessive accumulation of the ganglioside GM2 and related glycolipids in neuronal lysosomes ofthe brain and peripheral nervous system (1) . The disease is caused by muta- tions in either of two proteins: the lysosomal fl-hexosaminidase, which cleaves the terminal hexosamine from GM2 ganglioside; or a GM2 activator protein, which complexes with the lipid substrate and presents it to the enzyme for cleavage.
Lysosomal ,B-hexosaminidase consists of two major isozymes, hexosaminidase A (Hex A)' and hexosaminidase B (Hex B). Hex A is composed of an a-and 13-subunit, whereas Hex B is composed oftwo 13-subunits (reviewed in reference 2). Hex A is the only isozyme that uses GM2 ganglioside as a substrate, although both isozymes can hydrolyse other glycolipids and artificial substrates (3) . This difference in substrate specificity is attributed to unique substrate binding sites in aand fl-subunits (4) . The a-subunit is encoded by the HEXA gene on chromosome 15 and the 13-subunit is encoded by the HEXB gene on chromosome 5 (5) . The GM2 activator gene has been localized to chromosome 5 (6) . Mutations of these genes result in the three variant forms of GM2 gangliosidosis: TaySachs disease (variant B) is due to a defective a-subunit, resulting in deficiency of Hex A activity (7); Sandhoff disease (variant 0) is due to a defective 13-subunit, resulting in a deficiency of Hex A and Hex B activity (8) ; and variant AB is due to a defective GM2 activator protein (9) .
Patients with GM2 gangliosidosis show a wide range of clinical severity and are further classified as infantile, late infantile, juvenile, and adult cases depending on the age of onset and severity of the disease. Although there is no sharp distinction between these subtypes, the broad group does relate to the severity of the biochemical lesion. For example, we have previously shown that the juvenile-onset form ofSandhoffdisease can be biochemically differentiated from the infantile-onset form by the amount of residual Hex A activity in established fibroblast cell lines (10) . Further, there have been three reports describing an adult-onset form of the disease (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) . The disorder in these patients was limited to a motor neuron disease, presumably owing to only a partial deficiency of 13-hexosaminidase. Finally, there is one case reported in which a normal individual with no apparent symptoms has a complete Hex A and Hex B deficiency when assayed with the artificial substrate but a carrier-like activity when assayed with the natural substrate (15) .
Unlike Tay-Sachs disease, which has a high carrier frequency in the Ashkenazi Jewish population, no predominant ethnic group has been shown with a high Sandhoff disease carrier frequency (1) . However, there are several geographic or demographic isolates with a high incidence of the disease. For example, there is an inbred community ofMetis (North American Indians) in Northern Saskatchewan in which three cases of the disease have been described (16) . 7 cases have been described in Lebanon (17) and an astonishing 36 cases in 15 families (over a 3-yr period) have been described in the Creole population of Argentina (18) .
A thorough investigation of mutations in Sandhoffdisease is important for two major reasons. First, it would allow the introduction of DNA-based diagnosis of specific mutations in the disease. Secondly, the mutations would provide clues about the functional domains of 13-hexosaminidase that are important for lysosomal targeting and enzymatic activity. Little progress has been made in identifying mutations at the HEXB gene. Thus far, only one mutation has been deter-mined: a point mutation in intron 12 in a patient with the juvenile form of Sandhoff disease (19) . We had previously identified a partial HEXB gene deletion in an individual with the infantile form of Sandhoff disease. We now show that the deletion appears to have resulted from an Alu-Alu recombination and that the mutant allele is prevalent in diverse populations expressing this disease.
Methods
The fibroblast cell lines GM3 17 and GM294 were obtained from the Human Genetic Mutant Cell Line Repository (Camden, NJ). The cell lines were maintained and propagated in a-MEM media supplemented with 10% FCS. Genomic DNA from cells was isolated as described previously (20 These were screened as described previously (22) with two genomic probes, EH1. I and Pst 1.0 (see Results).
Analysis of recombinant clones. DNA from purified phage clones was isolated as described (23) . The DNA was analyzed by various restriction enzymes and compared with normal genomic clones previously isolated (22) . DNA fragments were subcloned into Bluescript vectors (Stratagene Corp.) and further mapped as described previously (22) .
DNA sequencing. Fragments to be sequenced were subcloned into either pBS(+) or pBS(-). Fragments not having clonable ends were made blunt by treatment with Klenow (Bethesda Research Laboratories) or T4 polymerase (Pharmacia) as described by Maniatis et al. (24) . Single-stranded DNA was isolated and sequenced as described previously (22) . DNA amplification. The mutant alleles in Sandhoff cell lines were examined by the polymerase chain reaction (PCR) procedure. The deletion allele (see below) was amplified by PCR with primers flanking the deletion junctions (Fig. 5) . The normal allele was detected using primers in exon 4 (5'-GAGACCTTTAGCCAGTrAGT) and exon 5 (5'-AGAATAATCTTAACTGGCAG). The amplifications were done in 50-Ml reactions containing 0.2-0.5 Mg ofDNA, 10 mM Tris-HCI (pH 8.3), 50 mM KCI, 1.5 mM MgCI2, 1.5 mM of each dNTPs, 0.01% gelatin, I MAM of each primer, and 2.5 U of Taq polymerase (PerkinElmer Cetus Corp., Norwalk, CT). The reactions were run in a Cetus/ Perkin-Elmer DNA thermal cycler for 35 cycles, each consisting of denaturation at 94°C for 0.5 min, annealing at 55 or 60°C (for normal and mutant reactions, respectively) for 0.5 min and extension at 72°C for 1.5 min. The amplified products were analyzed on a 1.5% agarose gel.
Results
Southern blot analysis of genomic DNA from Sandhoff cell lines GM317 and GM294, using the d-subunit cDNA as probe, had previously revealed a partial HEXB gene deletion at the 5' end (10) . To further localize these deletions, Southern blot analysis was carried out with various genomic probes subcloned from the HEXB gene. Two probes were informative. One was EHl.l, a 1.1-kb Eco RI-Hinc II fragment 5 kb upstream of exon 1 (Fig. 1) . It detected single DNA fragments after cleavage of genomic DNA with Eco RI, Bam HI, Hind III, Xba I, and Pst I (Fig. 2) . Two DNA fragments are detected with Sst I, since the probe spans a Sst I site, a 5' 8-kb fragment and a 3' 12-kb fragment (Fig. 2 B) . Since the probe hybridizes to only -200 bp ofthe 5'8-kb band, as compared with 900 bp of the 3' 12-kb band (see restriction map in Fig. 1 ), the 8-kb band is barely detectable (Fig. 2 B) . The second informative probe, Pst 1.0, spans exon 6 ( Fig. 1 ) and has been previously described (25) . It detects single HEXB gene fragments (Fig. 3 , arrows) as well as other DNA fragments unrelated to the HEXB gene with some restriction enzymes (e.g. Fig. 3 , lower bands in Bam HI and Hind III digests). When Southern blots were probed with EH 1.1, abnormal restriction fragments were revealed in the DNA of both GM3 17 and GM294 fibroblasts after cleavage with Eco RI, Bam HI, Hind III, and Pst I, but not with Xba I (Fig. 2 ). An abnormal 4-kb fragment was also detected with Sst I; however, the 5' 8-kb fragment was unaltered ( Fig. 2 B) . When the same blots were probed with Pst 1.0, abnormal fragments were detected with Eco RI and Hind III ( Fig. 3 ) as well as with Bam HI (see below), but not with the Sst I, Pst I, and Xba I (data not shown). Significantly, the abnormal Eco RI and Hind III fragments detected by both probes were of similar mobility (compare Fig. 2A and 3 Fig. 3 ). Finally, there was no hybridization of exon 4-or 5-specific probes to the mutant DNAs (data not shown). These data suggest the deletions in GM317 and GM294 were likely identical to each other and in the homozygous state.
These results localized the deletions to a region beginning The deletion junction was further identified by obtaining a detailed restriction map (Fig. 4) and sequencing across the site of the deletion in mutant DNA (2.0-kb Xba I fragment of GM317) and the corresponding 5' site (0.3-kb Eco RI-Xba I fragment) and 3' site (1.6-kb Sst I-Xho I fragment) in normal DNA (Figs. 1 and 4) . Comparison of the nucleotide sequence across the deletion and the corresponding junction sites in normal DNA revealed that the breakpoint occurred within a span of 29 nucleotides that are identical at the 5' and 3' sites in normal DNA (Fig. 5, uppercase) . The DNA sequence of the deletion clone on either side of this region matches perfectly the 5' and 3' normal sequence, indicating that no insertion or addition of extraneous DNA sequences has occurred during the deletion event. Computer-assisted analysis of the sequences around the deletion junctions indicated that these sequences are homologous to the Alu repetitive element. Furthermore, the deletion event has resulted in a reconstituted Alu sequence, the left half of which is from the 5' Alu sequence and the right half of which is from the 3' Alu sequence (Fig. 5, solid bar over and underneath the sequence). Sequencing of other DNA fragments from intron 5 revealed the presence of additional Alu sequences that are schematically shown in Fig. 4 .
We next used PCR to compare the deletions in GM317 and GM294 and to determine if the mutant allele was present in other Sandhoff cell lines. The normal allele was detected using primers contained within the deletion segment, one in exon 4 and other in exon 5 to give a PCR product of 385 bp (see Methods). The deletion allele was amplified using primers flanking the deletion junction (Fig. 5) . They yielded a PCR product of 506 bp when the deletion was present but no product with normal DNA since the primers were -16 kb apart, although, in some experiments, an aberrant band of -800 bp could be seen with normal DNA (Fig. 6 A) . When DNA from GM317 was used, only the 506-bp band was observed, confirming the presence of the deletion in the homozygous state (Fig. 6) . DNA from GM294 behaved identically, giving the 506-but no 385-bp PCR product (Fig. 6) PCR products by cleavage with several restriction enzymes also showed them to be identical (data not shown). We conclude, therefore that GM3 17 and GM294 carry the same mutant allele. The occurrence of the deletion allele was next examined in 20 different Sandhoff cell lines that are clinically and ethnically diverse. The mutation was present in four additional cell lines, WG534, 2399, 2557, and GM 2094 (Fig. 6 ). All these cell lines proved to be compound heterozygous since both the 506-and 385-bp fragments were detected in each case (Fig. 6) . Our previous analysis of some of these cell lines by Southern blot hybridization using the cDNA as probe did not reveal the presence of the deletion allele. We surmise that it generated a large restriction fragment that was either undetectable or masked by the non-deleted allele. The results of the PCR analysis for all the Sandhoff cell lines is shown in Table 1 . The mutation was observed in 8/30 or 27% of mutant alleles in our collection of Sandhoff disease cell lines.
Finally, we have confirmed the presence of the intron 12 point mutation by allele-specific hybridization of PCR products in GM 2094 (data not shown) as reported by Nakano and Suzuki (19) . This intron 12 mutation was not present in any of the other Sandhoff cell lines listed in Table I .
Discussion
In this study, we have identified the structure and distribution of a deletion mutation prevalent in Sandhoff disease. The deletion is -16 kb long and spans from -2 kb upstream of exon I to within the first -1.5 kb of intron 5. Two individuals homozygous for the deletion had the severe, infantile form of Sandhoff disease and died by the age of 18 mo (26, 27) . Cell lines from both patients had undetectable HEXB mRNA (10) or hexosaminidase f3-subunits (28), owing to the absence of the HEXB promoter or 5' coding sequences (22) .
It is clear from the sequence ofthe deletion junction and of the deletion end points in the normal gene that Alu sequences are involved. Alu sequences are moderately repetitive sequences present at -500,000 copies in the haploid human genome (29) . They consist of a -300-bp sequence that originated from a duplication of a 1 50-bp sequence (29) . The left half of the dimer differs from the right due to a 3 1-bp insertion and the Alu sequence is terminated by a poly A-like structure. The entire structure is flanked by direct repeats that vary in length from 7 to 25 bp. The deletion end points at the 5 A similar Alu-type deletion has been described at the HEXA gene in Tay-Sachs disease (31) . Here exon 1 and 7 kb of flanking DNA were deleted due to an apparent Alu recombination. In this instance, the 5' deletion boundary sequence corresponds not to an Alu repeat per se but to a sequence homologous to the left halfofan Alu dimer. The exact deletion junction was shown to be 85 bp upstream of this Alu-like sequence. Deletions involving Alu repeats seems to account for a large number of mutations in other genes, e.g., in the LDL receptor genes (32, 33) the y, 6, f3-globin gene complex (34, 35) , and apolipoproteins B gene (36) . One notable difference between the deletion we have described and other AluAlu deletions is that most other deletion junctions seem to be clustered in the left arm of the Alu sequence in a region implicated in transcription by RNA The four individuals with Sandhoff disease who are heterozygous for the deletion covered the spectrum of onset and severity of the disease. Since the deletion homozygotes have a typical infantile form of the disease, any amelioration of the clinical phenotype in those heterozygous for the deletion must be due to the expression of the second allele only. Thus, the intron 12 mutation described by Nakano and Suzuki (19) is responsible for the juvenile phenotype in that patient. This 
